Harley Jacobsen Clinical Trial Participant Income Exemption Act of 2026

This bill would change federal tax law so that payments people receive for taking part in an approved clinical trial are not counted as taxable income. This covers payments for the person's own participation or a dependent's participation, as well as payments that reimburse or cover reasonable and necessary expenses of taking part. The tax change would apply to amounts paid after December 31, 2025. The bill would also bar these payments from being counted as income or resources when deciding whether someone qualifies for, or how much they receive from, federal programs or state and local programs paid for in whole or in part with federal funds.

Full text and official record on Congress.gov

Sponsors

• Jim Banks Republican sponsor
• 2 cosponsors